Contact Us

BUSINESS NEWS

mF International Limited Announces First Six Months of Fiscal Year 2024 Financial Results

Oct 17, 2024

HONG KONG,Oct. 17,2024--mF International Limited (the "Company" or "mF International") (Nasdaq: MFI),a Hong Kong-based experienced financial trading solution provider,today announc

C-STAR Appoints Industry Icon Mitch Presnick as Chief Advisor

Oct 17, 2024

NEW YORK,Oct. 17,2024-- C-STAR,a tech-empowered real estate investment company,is pleased to announce the appointment of Mitch Presnick as Chief Advisor. A seasoned investor and entrepreneur with ove

FP Markets Team Attends Forex Expo Dubai 2024 And Brings Home Two Awards

Oct 17, 2024

SYDNEY,Oct. 17,2024-- FP Markets,a global multi-asset Forexand CFDbroker,participated in the Forex Expo Dubai 2024 earlier this month. The largest trading event in the Middle East took place in Dubai

DZS Sells Service Assurance and WiFi Management Software Portfolio to AXON Networks

Oct 17, 2024

Transaction expands the strategic partnership between both companies and enables DZS to focus on its category-defining Broadband Networking,Connectivity and Cloud Edge portfolio

Colliers Project Leaders, Middle East secures $250-million World Trade Center, Yerevan project

Oct 17, 2024

YEREVAN,Armenia,Oct. 17,2024-- Leading diversified project management firm,Colliers Project Leaders,Middle East,has won the mandate to deliver end-to-end project management solutions for Armenia\'s n

BioCity will present the late-breaking clinical trial data of its ETA selective antagonist SC0062 at the American Society of Nephrology (ASN) 2024 with simultaneous publication of the trial data in the Journal of the American Society of Nephrology (JASN)

Oct 15, 2024

SHANGHAI,Oct. 14,2024--BioCity Biopharma announced that a late-breaking clinical trial abstract of its endothelin receptor type A (ETA) selective antagonist SC0062 has been selected for oral presentat

1 ... 258 259 260 261 262 263 264 ... 359